Chemoinformaics analysis of 6-(PENTADECYL)-SALICYLIC-ACID
| Molecular Weight | 320.473 | nRot | 13 |
| Heavy Atom Molecular Weight | 288.217 | nRig | 7 |
| Exact Molecular Weight | 320.235 | nRing | 1 |
| Solubility: LogS | -3.286 | nHRing | 0 |
| Solubility: LogP | 7.475 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 57.1434 |
| nHD | 2 | BPOL | 32.9706 |
| QED | 0.442 |
| Synth | 2.027 |
| Natural Product Likeliness | 0.554 |
| NR-PPAR-gamma | 0.977 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -5.033 |
| MDCK | 0.0000194 |
| BBB | 0.039 |
| PPB | 0.996256 |
| VDSS | 0.438 |
| FU | 0.00674193 |
| CYP1A2-inh | 0.396 |
| CYP1A2-sub | 0.185 |
| CYP2c19-inh | 0.481 |
| CYP2c19-sub | 0.063 |
| CYP2c9-inh | 0.249 |
| CYP2c9-sub | 0.732 |
| CYP2d6-inh | 0.689 |
| CYP2d6-sub | 0.084 |
| CYP3a4-inh | 0.098 |
| CYP3a4-sub | 0.021 |
| CL | 1.725 |
| T12 | 0.401 |
| hERG | 0.323 |
| Ames | 0.01 |
| ROA | 0.037 |
| SkinSen | 0.569 |
| Carcinogencity | 0.046 |
| EI | 0.982 |
| Respiratory | 0.888 |
| NR-Aromatase | 0.083 |
| Antiviral | Yes |
| Prediction | 0.601369 |